|
|
.
See Category: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
ICD-10 (CM) Code and Descriptor
|
D72.118 |
Other hypereosinophilic syndrome
|
D72118 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.43%
|
16.00%
|
10.14%
|
5.43%
|
3.00%
|
2.14%
|
3.00%
|
2.14%
|
1.00%
|
0.86%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D72.118*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
196
|
197
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
154
|
157
|
|
80053
|
COMPREHEN METABOLIC PANEL |
115
|
115
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
111
|
111
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
45
|
45
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
42
|
72
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
25
|
6,100
|
|
82607
|
VITAMIN B-12 |
20
|
20
|
|
88185
|
FLOWCYTOMETRY/TC ADD-ON |
20
|
250
|
|
82728
|
ASSAY OF FERRITIN |
18
|
18
|
|
83540
|
ASSAY OF IRON |
18
|
18
|
|
83550
|
IRON BINDING TEST |
17
|
17
|
|
86140
|
C-REACTIVE PROTEIN |
17
|
17
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
15
|
15
|
|
82785
|
ASSAY OF IGE |
15
|
15
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
15
|
17
|
|
J0517
|
INJ., BENRALIZUMAB, 1 MG |
13
|
390
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
13
|
34
|
|
Q3014
|
TELEHEALTH FACILITY FEE |
13
|
13
|
|
85027
|
COMPLETE CBC AUTOMATED |
11
|
11
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D72.118 related to the following DRG Codes:
814-816
|
